A studyof the pharmacokinetics of clidamycin in normal subjects and patients with chronic renal failure.

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Postgraduate medical journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 4467873PMCID PMC2496026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical uses and control of rifampicin and clindamycin.

  1971cited by this paper
• Clinical and Bacteriological Studies with Clindamycin

  1970cited by this paper
• Septicaemia and pulmonary embolism complicating use of arteriovenous fistula in maintenance haemodialysis.

  1970cited by this paper
• Microbiological and pharmacological behavior of 7-chlorolincomycin.

  1969cited by this paper
• Hemodialysis properties of clindamycin (7-chloro-7-deoxylincomycin).

  1969cited by this paper
• Maintenance haemodialysis.

  1969cited by this paper
• Comparative Studies of Antibacterial Activity In Vitro and Absorption and Excretion of Lincomycin and Clinimycin

  1968cited by this paper
• Absorption, excretion and half-life of clinimycin in normal adult males.

  1968cited by this paper
• Intermittent haemodialysis: insertion and care of the silastic-teflon cannula.

  1967cited by this paper

• Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis

  2023cites this paper
• The Risks of Using Trimethoprim/Sulfamethoxazole in Patients with Renal and Cardiac Compromise.

  2022cites this paper
• Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles

  2019cites this paper
• Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections

  2015cites this paper
• Chronic kidney disease: pharmacological considerations for the dentist.

  2010cites this paper
• Ex Vivo Protein Binding of Clindamycin in Sera With Normal and Elevated α1‐Acid Glycoprotein Concentrations

  1992cites this paper
• Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations.

  1992cites this paper
• Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal Function

  1992cites this paper
• Clindamycin: a review of fifteen years of experience.

  1982cites this paper
• Clindamycin.

  1982cites this paper
• Drug-disease interactions: a review of the literature.

  1981cites this paper
• Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics.

  1980cites this paper
• Using pharmacokinetics in drug therapy. VIII: Pharmacokinetic evaluation of antibiotic dosage regimens.

  1980cites this paper
• Serum and plasma concentrations of clindamycin following a single intramuscular injection of clindamycin phosphate in maintenance haemodialysis patients and normal subjects

  1978cites this paper
• Guidelines for drug therapy in renal failure.

  1977cites this paper
• Pharmaceutical sciences--1975: literature review of pharmaceutics II.

  1976cites this paper